Skip to main content
logo
Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
3.310
+0.170 (5.41%)
At close: Oct 7, 2025, 4:00 PM EDT
3.349
+0.039 (1.17%)
After-hours: Oct 7, 2025, 7:59 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Exemplar
6.15M
Log In
Log In
Log In
Log In
Upgrade
Exemplar Growth
-48.81%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals
75.00K
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals Growth
-99.50%
Log In
Log In
Log In
Log In
Upgrade
Trans Ova
-
Log In
Log In
Log In
Log In
Upgrade
Trans Ova Growth
-
Log In
Log In
Log In
Log In
Upgrade
Human Biotherapeutics
-
Log In
Log In
Log In
Log In
Upgrade
All Other
-
Log In
Log In
Log In
Log In
Upgrade
All Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
ActoBio
-
Log In
Log In
Log In
Log In
Upgrade
ActoBio Growth
-
Log In
Log In
Log In
Log In
Upgrade
PGEN Therapeutics, Inc.
-
Log In
Log In
Log In
Log In
Upgrade
PGEN Therapeutics, Inc. Growth
-
Log In
Log In
Log In
Log In
Upgrade
MBP Titan
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
6.23M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-76.66%
Log In
Log In
Log In
Log In
Upgrade
Foreign
-
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
-
Log In
Log In
Log In
Log In
Upgrade